Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05874141

Comorbidities in Type 2 Diabetes Mellitus

Comorbidities in Type 2 Diabetes Mellitus: An Observational Study in Kharga City, New Valley Governate, Egypt

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
288 (estimated)
Sponsor
New Valley University · Academic / Other
Sex
All
Age
18 Years – 90 Years
Healthy volunteers
Not accepted

Summary

Type 2 diabetes mellitus (DM) has adopted a top priority as it is a disease with an increasing prevalence. The number of people living with DM has increased more than fourfold over the past 40 years to more than 460 million people today

Detailed description

All-cause mortality rates have declined substantially in several high-income countries, including England. A diversification in non-fatal conditions in people with DM has also been reported. This is attributable to broader, non-vascular conditions. Due to increasing longevity among people with type 2 DM with increasing and diversifying multimorbidity in them, the health needs of people with Type 2 DM are therefore likely to be broad, and complex. Finding multimorbidity (two or more chronic conditions) is common in people with Type 2 DM and increasing, but the comorbidity profiles of people with T2DM vary substantially. Many studies have primarily focused on identifying multimorbidity patterns in the general population. The understanding of multimorbidity patterns and composition of specific comorbidities in people with DM, and how this varies across patient groups and during the course of the disease, is limited. Further knowledge of this could provide insight into providing more holistic and more personal approaches to clinical guideline development, care pathways, and secondary prevention.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTHBA1Cblood sample on EDTA
DIAGNOSTIC_TESTLipid profile, including total, LDL, and HDL cholesterol and Triglyceridesserum sample
DIAGNOSTIC_TESTUrine analysis and urinary albumin-to-creatinine ratioMorning urine sample
DIAGNOSTIC_TESTSerum creatinine and estimated glomerular filtration rateserum sample
DIAGNOSTIC_TESTComplete blood countblood sample on EDTA
DIAGNOSTIC_TESTThyroid-stimulating hormoneserum sample
DIAGNOSTIC_TESTSerum iron, TIBC, Transferrin saturation and serum ferritin if neededserum sample
PROCEDUREElectrocardiography (ECG)by electrocardiogram
PROCEDURETransthoracic echocardiography, Neck ultrasonography if needed and abdominopelvic ultrasoundimaging
PROCEDUREArterial duplex ultrasound of both lower limbsimaging
DIAGNOSTIC_TESTRandom blood glucoseserum sample
DIAGNOSTIC_TESTAST, ALT, albuminserum sample

Timeline

Start date
2023-11-15
Primary completion
2025-12-30
Completion
2026-08-30
First posted
2023-05-24
Last updated
2025-08-14

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT05874141. Inclusion in this directory is not an endorsement.